CVS Health Files Q1 2024 10-Q
Ticker: CVS · Form: 10-Q · Filed: 2024-05-01T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
CVS Health's Q1 2024 10-Q is in. Check financials vs. last year.
AI Summary
CVS Health Corp. filed its 10-Q for the period ending March 31, 2024. The filing details financial performance for the first quarter of 2024, comparing it to the same period in 2023. Key financial data and balance sheet information as of March 31, 2024, December 31, 2023, and December 31, 2022, are presented.
Why It Matters
This filing provides investors with the latest financial performance data for CVS Health, crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Numbers
- 2024 Q1 — Reporting Period (First quarter of 2024 financial performance)
- 2023 Q1 — Prior Period (Comparison period for Q1 2024 results)
- 2024-03-31 — Balance Sheet Date (Key financial position as of end of Q1 2024)
- 2023-12-31 — Prior Balance Sheet Date (Financial position as of year-end 2023)
Key Players & Entities
- CVS HEALTH Corp (company) — Filer
- 0000064803 (company) — Central Index Key
- 20240331 (date) — Period of Report
- 20240501 (date) — Filed as of Date
- 4017651500 (dollar_amount) — Business Phone
FAQ
What were the key financial highlights for CVS Health in Q1 2024 compared to Q1 2023?
The filing provides comparative data for the periods ending March 31, 2024, and March 31, 2023, for both product and service revenues, though specific dollar amounts for these comparisons are not detailed in the provided header information.
What is CVS Health's fiscal year end?
CVS Health's fiscal year ends on December 31st.
When was the company formerly known as CVS CAREMARK CORP?
The company was formerly known as CVS CAREMARK CORP until a name change on May 9, 2007.
What is the company's primary business classification?
CVS Health Corp. is classified under RETAIL-DRUG STORES AND PROPRIETARY STORES [5912].
What is the filing date and reporting period for this 10-Q?
This 10-Q filing has a conforming period of report of March 31, 2024, and was filed on May 1, 2024.
From the Filing
0000064803-24-000016.txt : 20240501 0000064803-24-000016.hdr.sgml : 20240501 20240501064000 ACCESSION NUMBER: 0000064803-24-000016 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 91 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240501 DATE AS OF CHANGE: 20240501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 24899973 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 10-Q 1 cvs-20240331.htm 10-Q cvs-20240331 0000064803 12/31 2024 Q1 false http://fasb.org/us-gaap/2023#ProductMember http://fasb.org/us-gaap/2023#ProductMember 0000064803 2024-01-01 2024-03-31 0000064803 2024-04-24 xbrli:shares 0000064803 us-gaap:ProductMember 2024-01-01 2024-03-31 iso4217:USD 0000064803 us-gaap:ProductMember 2023-01-01 2023-03-31 0000064803 2023-01-01 2023-03-31 0000064803 us-gaap:ServiceMember 2024-01-01 2024-03-31 0000064803 us-gaap:ServiceMember 2023-01-01 2023-03-31 iso4217:USD xbrli:shares 0000064803 2024-03-31 0000064803 2023-12-31 0000064803 2022-12-31 0000064803 2023-03-31 0000064803 us-gaap:CommonStockMember 2023-12-31 0000064803 us-gaap:TreasuryStockCommonMember 2023-12-31 0000064803 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-12-31 0000064803 us-gaap:RetainedEarningsMember 2023-12-31 0000064803 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000064803 us-gaap:ParentMember 2023-12-31 0000064803 us-gaap:NoncontrollingInterestMember 2023-12-31 0000064803 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000064803 us-gaap:ParentMember 2024-01-01 2024-03-31 0000064803 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0000064803 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000064803 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000064803 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000064803 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0000064803 us-gaap:CommonStockMember 2024-03-31 0000064803 us-gaap:TreasuryStockCommonMember 2024-03-31 0000064803 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2024-03-31 0000064803 us-gaap:RetainedEarningsMember 2024-03-31 0000064803 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000064803 us-gaap:ParentMember 2024-03-31 0000064803 us-gaap:NoncontrollingInterestMember 2024-03-31 0000064803 us-gaap:CommonStockMember 2022-12-31 0000064803 us-gaap:TreasuryStockCommonMember 2022-12-31 0000064803 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2022-12-31 0000064803 us-gaap:RetainedEarningsMember 2022-12-31 0000064803 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000064803 us-gaap:ParentMember 2022-12-31 0000064803 us-gaap:NoncontrollingInterestMember 2022-12-31 0000064803 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000064803 us-gaap:ParentMember 2023-01-01 2023-03-31 0000064803 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0000064803 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000064803 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000064803 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000064803 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0000064803 us-gaap:CommonStockMember 2023-03-31 0000064803 us-gaap:TreasuryStockCommonMemb